Cynthia Collins Editas Medicine, Inc. (EDIT) insider trading activity

EDIT Quotes by TradingView

Cynthia Collins is CEO of Editas Medicine, Inc.. Currently has a direct ownership of 43,760 shares of EDIT, which is worth approximately $152,722. The most recent transaction as insider was on Feb 09, 2021, when has been sold 1,262 shares (Common Stock) at a price of $66.65 per share, resulting in proceeds of $84,112. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.8K
0% 3M change
0% 12M change
Total Value Held $152,722

Cynthia Collins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2021
SELL
Open market or private sale
$84,112 $66.65 p/Share
1,262 Reduced 2.8%
43,760 Common Stock

Also insider at

DMTK
DermTech, Inc. Healthcare
Director
PSTX
Poseida Therapeutics, Inc. Healthcare
CERT
Certara, Inc. Healthcare
CC

Cynthia Collins

CEO
Princeton, NJ

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EDIT